Intestinal Flora Sequencing for Nasopharyngeal Carcinoma
NCT04094545 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 568
Last updated 2019-09-19
Summary
This study investigated the correlation between the changes in the intestinal flora and NPC by an examination of the intestinal flora and multiple clinical indicators of the blood of 8 carefully screened patients of familial NPC, 24 patients of sporadic NPC and 27 healthy controls and a comparison of the differences in their intestinal flora structures and biological functions. By analyzing the function of the intestinal floras of NPC patients, we aimed to provide a better biological marker for patients with familial and sporadic NPC and constructed a disease prediction model for high-risk populations.
Conditions
- Nasopharyngeal Carcinoma
Sponsors & Collaborators
-
The Third Xiangya Hospital of Central South University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-08-01
- Primary Completion
- 2018-12-31
- Completion
- 2019-05-30
Countries
- China
Study Locations
More Related Trials
-
Gut Microbiota Reconstruction for NSCLC Immunotherapy
NCT05008861 ·Status: UNKNOWN ·Phase: PHASE1
-
Neoantigen-based Peptide Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment
NCT06751914 ·Status: RECRUITING ·Phase: NA
-
Neoantigen-based Peptide Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment
NCT06751966 ·Status: RECRUITING ·Phase: NA
-
Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Therapy for Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery
NCT00960427 ·Status: WITHDRAWN ·Phase: PHASE1
-
The Impact of Immune Cell Changes During the Perioperative Period on the Prognosis of Patients With Colorectal Cancer
NCT05015296 ·Status: UNKNOWN
-
Analysis of Gut Microbiota in Patients With Brain Metastasis of Non-small Cell Lung Cancer Treated by Pembrolizumab Combined With Chemotherapy
NCT04333004 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Exploratory Study of Intermittent Hypoxia Intervention on Colorectal Cancer
NCT06584318 ·Status: RECRUITING ·Phase: NA
-
Utilization of Microbiome as Biomarkers and Therapeutics in Immuno-Oncology
NCT04264975 ·Status: RECRUITING ·Phase: NA
-
Prognostic Biomarker for CRC
NCT03928652 ·Status: UNKNOWN
-
FMT+Immunotherapy+Chemotherapy As First-line Treatment for Driver-gene Negative Advanced NSCLC
NCT06403111 ·Status: RECRUITING ·Phase: PHASE2
-
Potential Predictive Biomarkers in Patients Undergoing First-line Chemotherapy for Metastatic Colorectal Cancer
NCT03532711 ·Status: COMPLETED
-
Detect Microsatellite Instability Status in Blood Sample of Advanced Colorectal Cancer Patients by Next-Generation Sequencing
NCT03561350 ·Status: UNKNOWN
-
Dietary Fiber and Probiotics in Advanced Colorectal Cancer
NCT07194954 ·Status: COMPLETED ·Phase: NA
-
Biomarkers in Patients With Rectal Cancer Undergoing Chemotherapy and Radiation Therapy
NCT00280761 ·Status: COMPLETED
-
To Explore the Diversity of Intestinal Flora in Patients With Advanced HCC Combin ed With Anti-PD-1 and Targeted Drug Therapy and the Correlation Between Metabolites and Therapeutic Effect
NCT04101747 ·Status: UNKNOWN
-
Impact of Body Mass Index and Lipid Metabolism on Anti-PD-1 Immunotherapy Outcomes in Colorectal Cancer
NCT07012174 ·Status: COMPLETED
-
Anti-PD-1 Antibody Combined With Autologous DC and NK Cells in the Treatment of Digestive Carcinoma
NCT05461235 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Surgical Treatment and Molecular Marker Exploration of Locally Recurrent Colorectal Cancer
NCT06114420 ·Status: RECRUITING
-
Significance of Cortactin Expression in Colorectal Adenocarcinomas
NCT05225870 ·Status: COMPLETED ·Phase: NA
-
Clinicopathological Characteristics of Colon Cancer in Young Age
NCT05365412 ·Status: RECRUITING
-
Nutrition and Lifestyle Study Cohort of Gastric Cancer in China
NCT02216955 ·Status: UNKNOWN
-
Epiction of the Genomic and Genetic Landscape Identifies CCL5 as a Protective Factor in Colorectal Neuroendocrine Carcinoma
NCT05714722 ·Status: COMPLETED
-
Regorafenib Treatment Patterns and Survival Outcomes in Advanced Colorectal Cancer: A Real-world Study
NCT04835324 ·Status: UNKNOWN
-
PDL1 In Primary Colorectal Carcinoma and Its Prognostic Impact
NCT05692895 ·Status: UNKNOWN
-
Microbiota and Carcinogenesis of Small-intestine Neuroendocrine Tumors
NCT06624865 ·Status: RECRUITING